FocusPoint works closely with the Pharmaceutical & Biotech sector to address challenges ranging from unfair competition, IP issues, regulatory exposure, product tamper, threats from political and animal-rights activists and disruption in the supply chain.

Our exposure includes partner due diligence, pre-transactional due diligence, market entry analysis, security master planning, close protection in medium to high risk countries, counterfeit and gray market investigations.

Key services and areas of focus include:

• Country Risk Assessments
• Market Entry Analysis
• TSCM
• Pre-transactional Due Diligence
• Brand Protection
• Security Assessments
• Close Protection
• Partner Due Diligence
• Business Resiliency Planning
• Incident Management & Crisis Response